finance

Gilead Sciences could jump nearly 30% as biopharma bounces back, says Bank of America


Readers Also Like:  ‘Outrageous’ Shell bonus triggers call for higher windfall tax – but UK firms take hit from levy



READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.